New York, May 27, 2019 As an international biotech company, Creative Biolabs has focused on antibody-drug conjugate field for over 10 years and now is capable of offering a full list of target-oriented antibody-drug conjugates for global clients to serve the course of ADC services for development and evaluation.
Compared to conventional monoclonal antibodies, Antibody-drug conjugates (ADCs) not only inherit the superiorities of high specificity and affinity, but also expand the therapeutic window of the conjugated drugs (payloads), which are usually highly toxic and diverse in their biochemical nature. Endowed with these superb advantages, ADCs play a more and more popular role in both scientific and industrial fields.
Based on years of practical experiences and a professional team, Creative Biolabs offers a comprehensive one-stop-shop ADC services to help create highly customized ADCs, extending from the starting point—antibody identification, to the final destination—creation and evaluation of the ADC, every step of the way, which mainly include antibody screening services, DrugLnk™ Custom Synthesis, antibody design and conjugation, ADC in vitro/vivo Analysis, Antibody-based Probes.
Taking advantage of the large inventory of therapeutic antibodies, scientists in Creative Biolabs can create the ADC custom products by conjugating therapeutic antibodies against cancer surface antigens with different drug-linker complexes. These high-quality custom ADCs are suitable for tasks such as proof-of-concept, target validation, as well as control to provide comparison in efficacy for new ADC development projects.
With Ph.D. level scientists and over a decade of experience in recombinant antibody production, antibody engineering, synthetic chemistry, and bioconjugation, Creative Biolabs is dedicated to serving the unique needs of clients in ADC development projects by providing customized services that are tailored to meet R&D timeline and budget. More detailed information can be reached at https://www.creative-biolabs.com/adc.
With more than a decade of exploration and expansion, Creative Biolabs provides current research and service capacity that covers the entire new drug discovery and development pipeline, ranging from early discovery, pre-clinical evaluations, cGMP manufacturing, to clinical trials. As an international cooperation, Creative Biolabs established offices all around the globe with more than 200 well-trained full-time scientists and technicians, who work closely with customers and research partners to develop new medicines for a better, healthier world. After years of pursuit for perfection, Creative Biolabs has established leadership in targeted immunotherapy and antibody-drug conjugate (ADC) development. They offer customers comprehensive one-stop-shop of all aspects in ADC research and evaluation, ranging from antigen selection, antibody production/optimization, payload-linker synthesis, ADC conjugation, to various stages of ADC characterization and pre-clinical evaluation.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States